173 related articles for article (PubMed ID: 31314777)
1. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
Lanki M; Seppänen H; Mustonen H; Hagström J; Haglund C
PLoS One; 2019; 14(7):e0219245. PubMed ID: 31314777
[TBL] [Abstract][Full Text] [Related]
2. The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
Nurmi AM; Hagström J; Mustonen H; Seppänen H; Haglund C
PLoS One; 2022; 17(5):e0267792. PubMed ID: 35536778
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
[TBL] [Abstract][Full Text] [Related]
5. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
6. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C
Oncology; 2021; 99(9):589-600. PubMed ID: 34139707
[TBL] [Abstract][Full Text] [Related]
7. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Lehenkari P; Saarnio J; Karttunen TJ
Virchows Arch; 2017 Apr; 470(4):401-410. PubMed ID: 28191612
[TBL] [Abstract][Full Text] [Related]
8. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
[TBL] [Abstract][Full Text] [Related]
9. Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.
Sánchez-Muñoz F; Fonseca-Camarillo G; Villeda-Ramírez MA; Miranda-Pérez E; Mendivil EJ; Barreto-Zúñiga R; Uribe M; Bojalil R; Domínguez-López A; Yamamoto-Furusho JK
BMC Gastroenterol; 2011 Dec; 11():138. PubMed ID: 22185629
[TBL] [Abstract][Full Text] [Related]
10. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
[TBL] [Abstract][Full Text] [Related]
11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of Toll‑like receptors in human breast cancer.
Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
14. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
Radulović P; Krušlin B
Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
[TBL] [Abstract][Full Text] [Related]
17. Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma.
Yang JY; Jiang SH; Liu DJ; Yang XM; Huo YM; Li J; Hua R; Zhang ZG; Sun YW
Sci Rep; 2015 May; 5():10575. PubMed ID: 26015068
[TBL] [Abstract][Full Text] [Related]
18. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
[TBL] [Abstract][Full Text] [Related]
20. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
Mishra BB; Mishra PK; Teale JM
J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]